Market Exclusivity Decision Pending For Bayer’s First-In-Class OTC Switch Astepro Allergy

Astepro Allergy labeling was approved with Bayer's NDA for an OTC switch of azelastine hydrochloride nasal spray. • Source: FDA

More from Rx-to-OTC Switch

More from Health